AC Immune SA
NASDAQ:ACIU
Balance Sheet
Balance Sheet Decomposition
AC Immune SA
Current Assets | 125.2m |
Cash & Short-Term Investments | 103m |
Receivables | 15.7m |
Other Current Assets | 6.4m |
Non-Current Assets | 57.7m |
Long-Term Investments | 361k |
PP&E | 6.9m |
Intangibles | 50.4m |
Current Liabilities | 13.6m |
Accounts Payable | 1.7m |
Accrued Liabilities | 11.1m |
Other Current Liabilities | 810k |
Non-Current Liabilities | 8.6m |
Long-Term Debt | 2.8m |
Other Non-Current Liabilities | 5.8m |
Balance Sheet
AC Immune SA
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
3
|
77
|
152
|
124
|
157
|
194
|
161
|
82
|
32
|
78
|
|
Cash |
3
|
77
|
152
|
124
|
157
|
0
|
0
|
0
|
0
|
0
|
|
Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
194
|
161
|
82
|
32
|
78
|
|
Short-Term Investments |
0
|
0
|
0
|
0
|
30
|
95
|
65
|
116
|
91
|
25
|
|
Total Receivables |
26
|
0
|
1
|
4
|
4
|
1
|
2
|
1
|
1
|
16
|
|
Accounts Receivables |
0
|
0
|
1
|
3
|
4
|
1
|
2
|
1
|
0
|
15
|
|
Other Receivables |
26
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
|
Other Current Assets |
0
|
3
|
1
|
1
|
2
|
3
|
4
|
3
|
5
|
6
|
|
Total Current Assets |
30
|
79
|
155
|
130
|
193
|
293
|
232
|
203
|
128
|
125
|
|
PP&E Net |
1
|
1
|
1
|
2
|
3
|
6
|
7
|
8
|
7
|
7
|
|
PP&E Gross |
1
|
1
|
1
|
2
|
3
|
6
|
7
|
8
|
7
|
7
|
|
Accumulated Depreciation |
2
|
2
|
2
|
3
|
4
|
5
|
6
|
8
|
9
|
11
|
|
Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
50
|
50
|
50
|
|
Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Assets |
30
N/A
|
80
+164%
|
156
+95%
|
132
-15%
|
197
+49%
|
299
+52%
|
239
-20%
|
261
+10%
|
186
-29%
|
183
-2%
|
|
Liabilities | |||||||||||
Accounts Payable |
2
|
2
|
4
|
1
|
2
|
0
|
2
|
2
|
1
|
2
|
|
Accrued Liabilities |
3
|
4
|
5
|
8
|
10
|
12
|
11
|
17
|
9
|
11
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
|
Other Current Liabilities |
0
|
0
|
1
|
0
|
0
|
5
|
0
|
1
|
1
|
0
|
|
Total Current Liabilities |
4
|
6
|
10
|
10
|
13
|
18
|
14
|
20
|
12
|
14
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
3
|
|
Other Liabilities |
2
|
3
|
4
|
5
|
6
|
8
|
8
|
7
|
3
|
6
|
|
Total Liabilities |
7
N/A
|
9
+31%
|
14
+54%
|
15
+11%
|
19
+24%
|
27
+42%
|
23
-13%
|
30
+27%
|
17
-43%
|
22
+31%
|
|
Equity | |||||||||||
Common Stock |
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
|
Retained Earnings |
61
|
40
|
47
|
73
|
122
|
76
|
133
|
201
|
264
|
316
|
|
Additional Paid In Capital |
83
|
111
|
188
|
188
|
298
|
347
|
347
|
431
|
431
|
475
|
|
Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Equity |
24
N/A
|
71
+202%
|
142
+101%
|
117
-18%
|
178
+52%
|
272
+53%
|
216
-21%
|
232
+8%
|
169
-27%
|
161
-5%
|
|
Total Liabilities & Equity |
30
N/A
|
80
+164%
|
156
+95%
|
132
-15%
|
197
+49%
|
299
+52%
|
239
-20%
|
261
+10%
|
186
-29%
|
183
-2%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
54
|
54
|
57
|
57
|
68
|
72
|
72
|
84
|
84
|
99
|